MARKET

TOVX

TOVX

THERIVA BIOLOGICS INC
AMEX
0.2280
-0.0020
-0.87%
After Hours: 0.2308 +0.0028 +1.23% 19:59 08/14 EDT
OPEN
0.2350
PREV CLOSE
0.2300
HIGH
0.2379
LOW
0.2200
VOLUME
560.03K
TURNOVER
--
52 WEEK HIGH
0.8632
52 WEEK LOW
0.1628
MARKET CAP
10.46M
P/E (TTM)
-0.0893
1D
5D
1M
3M
1Y
5Y
1D
HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program
TipRanks · 4d ago
Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) Estimate
Benzinga · 5d ago
*Theriva Biologics Sees Cash Runway Into 1Q of 2027 >TOVX
Dow Jones · 5d ago
Press Release: Theriva(TM) Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results
Dow Jones · 5d ago
Press Release: Theriva(TM) Biologics Reports -2-
Dow Jones · 5d ago
Press Release: Theriva(TM) Biologics Reports -3-
Dow Jones · 5d ago
Weekly Report: what happened at TOVX last week (0803-0807)?
Weekly Report · 6d ago
Theriva Doses First Patient With VCN-01 In Phase 2a Trial For Pancreatic Cancer
NASDAQ · 08/07 06:06
More
About TOVX
Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. The Company is advancing a new oncolytic adenovirus platform. The Company’s candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a physical and immunosuppressive barrier to cancer treatment; SYN-004 (ribaxamase) which is designed to degrade certain commonly used IV beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome damage, thereby limiting overgrowth of pathogenic organisms such as VRE (vancomycin resistant Enterococci), and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases.

Webull offers Theriva Biologics Inc stock information, including AMEX: TOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TOVX stock methods without spending real money on the virtual paper trading platform.